key: cord-1038087-cbg82nrt
authors: Bertolaccini, Luca; Sedda, Giulia; Spaggiari, Lorenzo
title: Paying Another Tribute to the COVID-19 Pandemic: The Decrease of Early Lung Cancers
date: 2020-12-03
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2020.11.013
sha: 6c3e6c12f8fd33664f1305413f9f5bd9ea75ff34
doc_id: 1038087
cord_uid: cbg82nrt

nan

COronaVIrus Disease 19 (COVID-19) has strained the resilience of worldwide healthcare systems with the inevitable consequence of the pauperisation of oncological activities [1] . Even if COVID-19 should be accountable for upcoming worsened oncological survival outcomes [2] , several estimates were published without the analysis of clinical data [3] . The attribution of this reduction to a lower incidence of lung cancer is unrealistic. The stoppage of routine operations and the bulletins warning people to stay as far as possible from hospitals have caused adverse effects on lung cancer outcomes [4] . Likewise, the COVID-19 risks have also altered the balance of risk benefits of lung cancer screening. In 2019, the Nelson trial showed significantly lower lung cancer mortality among CT screened patients [5] . Recently, an American expert report considers appropriate the suspension of enrolment in LC screening during the COVID-19 pandemic [6] .

In conclusion, we have first demonstrated the redistribution of the lung cancer stages (with a significant increase of locally advanced stages) due to the lockdown measurements. The people's anxiety of going to hospitals as well as the reallocation of resources will cause diagnostic delays where the most acute effects could be seen in the first months of 2021. Therefore, even if there will not be another generalised lockdown, efforts should be made not to compromise the prognosis of lung cancer patients promoting the importance of screening for all individuals at risk. 

Cancer and COVID-19: Unmasking their ties

Reorganization of thoracic surgery activity in a national highvolume comprehensive cancer centre in the Italian epicentre of coronavirus disease

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Surviving the first COVID-19 wave and learning lessons for the second

Reduced lung-cancer mortality with volume CT screening in a randomized trial

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic